get a key
steadybase-$ company NRSN
account_id none on file
legal_name NeuroSense Therapeutics Ltd.
ticker NRSN
cik 1875091
domain neurosense-tx.com
entry_point_account_id none on file
exchange Nasdaq
sector Health Care
calls 0 filings 13 executives 5 family 0
why_nownone on file
callsnone on file
filings
2025, but does not include business travel, relocation, professional and business association dues and expenses reimbursed to officers,

filing / Mar 31, 2026 / receipt

In December 2021, the Company entered into an office space lease agreement (which commenced on January 1, 2022). Monthly rent payments including utilities amount to approximately $ 7 thousand and indexed to Israeli consumer price index.

filing / Mar 31, 2026 / receipt

healthcare industry and elsewhere is cost containment. Third party payors decide which drugs they will pay for and establish reimbursement and co-payment levels.

filing / Mar 31, 2026 / receipt

2021, we entered into an agreement which provides us access to co-working spaces, including office space in Cambridge, Massachusetts.

filing / Mar 31, 2026 / receipt

Alon Ben-Noon | Chief Executive Officer, Director | 46

filing / Mar 31, 2026 / receipt

Or Eisenberg | Chief Financial Officer | 44

filing / Mar 31, 2026 / receipt

Dr. Ferenc Tracik | Chief Medical Officer | 62

filing / Mar 31, 2026 / receipt

Dr. Niva Russek-Blum | Chief Technology Officer | 50

filing / Mar 31, 2026 / receipt

Hagit Binder | Chief Operating Officer | 47

filing / Mar 31, 2026 / receipt

2025, but does not include business travel, relocation, professional and business association dues and expenses reimbursed to officers,

filing / Mar 31, 2026 / receipt

In December 2021, the Company entered into an office space lease agreement (which commenced on January 1, 2022). Monthly rent payments including utilities amount to approximately $ 7 thousand and indexed to Israeli consumer price index.

filing / Mar 31, 2026 / receipt

healthcare industry and elsewhere is cost containment. Third party payors decide which drugs they will pay for and establish reimbursement and co-payment levels.

filing / Mar 31, 2026 / receipt

executives
Alon Ben-Noon Chief Executive Officer, Director - receipt
Dr. Ferenc Tracik Chief Medical Officer - receipt
Dr. Niva Russek-Blum Chief Technology Officer - receipt
Hagit Binder Chief Operating Officer - receipt
Or Eisenberg Chief Financial Officer linkedin receipt
familynone on file
upcomingnone on file
changesnone on file
mcp_package_hint
steadybase-$